Novavax, Inc., A Biotechnology Company Dedicated To Developing And Commercializing Next-Generation Vaccines For Serious Infectious Diseases, Today Announced That Partner Sk Bioscience Has Received Expanded Manufacturing And Marketing Approval From The Korean Ministry Of Food And Drug Safety (Kmfds) For Nuvaxovid
